Hoth Therapeutics, Inc. financial data

Symbol
HOTH on Nasdaq
Industry
Pharmaceutical Preparations
Location
590 Madison Avenue, 21 St Floor, New York, NY
State of incorporation
Nevada
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.11K % +46.3%
Debt-to-equity 9.96 % -45.4%
Return On Equity -81.8 % +28.6%
Return On Assets -74.4 % +23.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.9M shares +109%
Common Stock, Shares, Outstanding 5.36M shares +62.3%
Entity Public Float 9.8M USD -25.2%
Common Stock, Value, Issued 536 USD +62.4%
Weighted Average Number of Shares Outstanding, Basic 6.88M shares +108%
Weighted Average Number of Shares Outstanding, Diluted 6.88M shares +108%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.24B USD
Research and Development Expense 2.92M USD -36.5%
General and Administrative Expense 1.08M USD +2.18%
Costs and Expenses 29K USD
Operating Income (Loss) -7.49M USD +25.1%
Nonoperating Income (Expense) 28.7K USD
Net Income (Loss) Attributable to Parent -7.46M USD +26.7%
Earnings Per Share, Basic -1.55 USD/shares +74.6%
Earnings Per Share, Diluted -1.55 USD/shares +74.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.65M USD -16.4%
Marketable Securities, Current 24.6K USD
Assets, Current 9.95M USD -16.2%
Operating Lease, Right-of-Use Asset 41.1K USD
Other Assets, Noncurrent 85K USD
Assets 10M USD -15.8%
Accounts Payable, Current 333K USD -36%
Accrued Liabilities, Current 317K USD -72.7%
Liabilities, Current 681K USD -60.3%
Operating Lease, Liability, Noncurrent 11K USD
Liabilities 692K USD -64.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 23.1K USD
Retained Earnings (Accumulated Deficit) -56.6M USD -15.2%
Stockholders' Equity Attributable to Parent 9.34M USD -6.14%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 11.9M USD +50.5%
Liabilities and Equity 10M USD -15.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.72M USD +24.7%
Net Cash Provided by (Used in) Financing Activities 8.91M USD
Net Cash Provided by (Used in) Investing Activities -25K USD -103%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 5.36M shares +62.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.62M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.65M USD -16.4%
Deferred Tax Assets, Valuation Allowance 15.3M USD +19.5%
Deferred Tax Assets, Gross 15.3M USD +19.5%
Operating Lease, Liability 41.1K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.42M USD +27.6%
Lessee, Operating Lease, Liability, to be Paid 43.7K USD
Operating Lease, Liability, Current 30.1K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.9K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 32.8K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.61K USD
Deferred Tax Assets, Operating Loss Carryforwards 11.9M USD +14.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 65.9M USD +11.5%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 7.05K USD -27.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%